2 Biosimilars Make Their Way Toward the European Market Michele B. Kaufman, PharmD, BCGP | July 17, 2017Two biosimilar treatments, Rixathon and Imraldi, are moving closer to market release in Europe for the treatment of rheumatic and other diseases…